Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-017783
Filing Date
2016-05-05
Accepted
2016-05-05 06:46:32
Documents
59
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q srpt-10q_20160331.htm 10-Q 1752489
2 EX-31.1 srpt-ex311_6.htm EX-31.1 10564
3 EX-31.2 srpt-ex312_9.htm EX-31.2 10636
4 EX-32.1 srpt-ex321_7.htm EX-32.1 7305
5 EX-32.2 srpt-ex322_8.htm EX-32.2 7327
  Complete submission text file 0001564590-16-017783.txt   5219583

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT srpt-20160331.xml EX-101.INS 1134388
7 XBRL TAXONOMY EXTENSION SCHEMA srpt-20160331.xsd EX-101.SCH 31442
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20160331_cal.xml EX-101.CAL 40480
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20160331_def.xml EX-101.DEF 63677
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20160331_lab.xml EX-101.LAB 219735
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20160331_pre.xml EX-101.PRE 175633
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

EIN.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 161621470
SIC: 2834 Pharmaceutical Preparations